Improving lung health in low-income and middle-income countries: from challenges to solutions

J Meghji, K Mortimer, A Agusti, BW Allwood, I Asher… - The Lancet, 2021 - thelancet.com
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

International patterns of the prevalence of pediatric asthma: the ISAAC program

R Beasley, P Ellwood, I Asher - Pediatric Clinics, 2003 - pediatric.theclinics.com
Just as the occurrence of asthma and allergies can be studied at many different levels
including populations, individuals, organs, tissues, or cells, the causes of asthma can be …

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood

H Williams, C Robertson, A Stewart… - Journal of allergy and …, 1999 - Elsevier
Background: Little is known about the prevalence of atopic eczema outside Northern
Europe. Objectives: We sought to describe the magnitude and variation in the prevalence of …

Prevalence of asthma symptoms in Latin America: the International Study of Asthma and Allergies in Childhood (ISAAC)

J Mallol, D Solé, I Asher, T Clayton, R Stein… - Pediatric …, 2000 - Wiley Online Library
The prevalence of respiratory symptoms indicative of asthma in children from Latin America
has been largely ignored. As part of the International Study of Asthma and Allergies in …

Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults

J Chong, C Haran, BF Chauhan… - Cochrane Database of …, 2015 - cochranelibrary.com
Background International guidelines advocate using daily inhaled corticosteroids (ICS) in
the management of children and adults with persistent asthma. However, in real world …

Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study

SM Langan, AR Mulick, CE Rutter… - Clinical & …, 2023 - Wiley Online Library
Background Eczema (atopic dermatitis) is a major global public health issue with high
prevalence and morbidity. Our goal was to evaluate eczema prevalence over time, using …

A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals

T To, G Viegi, A Cruz, L Taborda-Barata… - European …, 2020 - Eur Respiratory Soc
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2)[1, 2]. The World Health Organization (WHO) …

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat …

MI Asher, S Montefort, B Björkstén, CKW Lai… - The lancet, 2006 - thelancet.com
Background Data for trends in prevalence of asthma, allergic rhinoconjunctivitis, and
eczema over time are scarce. We repeated the International Study of Asthma and Allergies …

Infection with SARS‐CoV‐2 among children with asthma: evidence from Global Asthma Network

CY Chiang, P Ellwood, E Ellwood… - Pediatric Allergy and …, 2022 - Wiley Online Library
Background Clinical presentations of coronavirus disease 2019 (COVID‐19) among
children with asthma have rarely been investigated. This study aimed to assess clinical …

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three

JA Odhiambo, HC Williams, TO Clayton… - Journal of Allergy and …, 2009 - Elsevier
BACKGROUND: In 1999, The International Study of Asthma and Allergies in Childhood
(ISAAC) Phase One reported the prevalence of eczema symptoms in 715,033 children from …